Related Experiment Video
Updated: May 21, 2026
09:56
Detection of Protease Activity by Fluorescent Peptide Zymography
Published on: January 20, 2019
Structure-Activity Relationship for Thiirane-Based Gelatinase Inhibitors
Mijoon Lee1, Masahiro Ikejiri, Dennis Klimpel
1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana 46556, USA.
ACS Medicinal Chemistry Letters
|June 28, 2012
Summary
Researchers explored structure-activity relationships of 2-(4-phenoxyphenylsulfonylmethyl)thiirane, a gelatinase inhibitor. Modifications, particularly substitutions on the terminal phenyl ring, enhanced inhibitory activity and metabolic stability.
Area of Science:
- Medicinal Chemistry
- Enzyme Inhibition
- Drug Discovery
Background:
- Human gelatinases are implicated in various pathological processes, including cancer metastasis and arthritis.
- 2-(4-phenoxyphenylsulfonylmethyl)thiirane (1) is a known potent and selective inhibitor of human gelatinases.
- Understanding structure-activity relationships is crucial for optimizing inhibitor efficacy and metabolic stability.
Purpose of the Study:
- To synthesize and evaluate novel analogs of compound 1 to explore structure-activity relationships.
- To identify key structural features responsible for gelatinase inhibition.
- To investigate the impact of substitutions on the terminal phenyl ring for improved activity and metabolic stability.
Main Methods:
- Multistep synthesis of 65 new analogs based on the 2-(4-phenoxyphenylsulfonylmethyl)thiirane template.
- Evaluation of inhibitory activity against human gelatinases.
- Metabolism studies to identify primary routes of biotransformation.
Main Results:
- The sulfonylmethylthiirane and phenoxyphenyl moieties are essential for gelatinase inhibition.
- Para- and meta-substitutions on the terminal phenyl ring significantly enhanced inhibitory potency.
- Substitutions also improved metabolic stability, with oxidation primarily occurring at the phenyl ring's para position and the sulfonyl group's alpha position.
Conclusions:
- Structural modifications of 2-(4-phenoxyphenylsulfonylmethyl)thiirane can lead to more potent and metabolically stable gelatinase inhibitors.
- Terminal phenyl ring substitutions represent a promising strategy for optimizing inhibitor properties.
- Metabolism studies provide insights into drug design for improved pharmacokinetic profiles.
Related Concept Videos
01:30Local Anesthetics: Chemistry and Structure-Activity Relationship
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...